
Misook Yu
Supervisory Patent Examiner (ID: 13848, Phone: (571)272-0839 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1641 |
| Total Applications | 878 |
| Issued Applications | 268 |
| Pending Applications | 204 |
| Abandoned Applications | 408 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4663126
[patent_doc_number] => 20080254033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases'
[patent_app_type] => utility
[patent_app_number] => 10/586669
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20161
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586669
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586669 | Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases | Jan 20, 2005 | Abandoned |
Array
(
[id] => 4663126
[patent_doc_number] => 20080254033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases'
[patent_app_type] => utility
[patent_app_number] => 10/586669
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20161
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586669
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586669 | Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases | Jan 20, 2005 | Abandoned |
Array
(
[id] => 7110563
[patent_doc_number] => 20050208018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth'
[patent_app_type] => utility
[patent_app_number] => 11/040162
[patent_app_country] => US
[patent_app_date] => 2005-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 19873
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208018.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040162
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040162 | Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth | Jan 19, 2005 | Issued |
Array
(
[id] => 5296025
[patent_doc_number] => 20090010951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same'
[patent_app_type] => utility
[patent_app_number] => 10/586852
[patent_app_country] => US
[patent_app_date] => 2005-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13837
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20090010951.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586852
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586852 | Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same | Jan 18, 2005 | Issued |
Array
(
[id] => 7196119
[patent_doc_number] => 20050164267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin'
[patent_app_type] => utility
[patent_app_number] => 11/036875
[patent_app_country] => US
[patent_app_date] => 2005-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14322
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164267.pdf
[firstpage_image] =>[orig_patent_app_number] => 11036875
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/036875 | Compositions and methods for identifying and targeting cancer cells of alimentary canal origin | Jan 13, 2005 | Issued |
Array
(
[id] => 4473982
[patent_doc_number] => 07867705
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-11
[patent_title] => 'Frizzled proteins and detection and treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/575627
[patent_app_country] => US
[patent_app_date] => 2005-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 48
[patent_no_of_words] => 36181
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/867/07867705.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575627
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575627 | Frizzled proteins and detection and treatment of cancer | Jan 4, 2005 | Issued |
Array
(
[id] => 7103894
[patent_doc_number] => 20050106620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Novel method of diagnosing, monitoring, staging, imaging and treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/022712
[patent_app_country] => US
[patent_app_date] => 2004-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6832
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106620.pdf
[firstpage_image] =>[orig_patent_app_number] => 11022712
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/022712 | Novel method of diagnosing, monitoring, staging, imaging and treating cancer | Dec 26, 2004 | Abandoned |
Array
(
[id] => 7045532
[patent_doc_number] => 20050250127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Methods for identifying modulators of MDA-7 mediated apoptosis'
[patent_app_type] => utility
[patent_app_number] => 11/019897
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14987
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250127.pdf
[firstpage_image] =>[orig_patent_app_number] => 11019897
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/019897 | Methods for identifying modulators of MDA-7 mediated apoptosis | Dec 21, 2004 | Abandoned |
Array
(
[id] => 7219161
[patent_doc_number] => 20050260555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Chemosensitivity measurement using caspase activity'
[patent_app_type] => utility
[patent_app_number] => 10/999158
[patent_app_country] => US
[patent_app_date] => 2004-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4446
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260555.pdf
[firstpage_image] =>[orig_patent_app_number] => 10999158
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/999158 | Chemosensitivity measurement using caspase activity | Nov 29, 2004 | Abandoned |
Array
(
[id] => 6983262
[patent_doc_number] => 20050153332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Method of diagnosing, monitoring, staging, imaging and treating colon cancer'
[patent_app_type] => utility
[patent_app_number] => 11/000263
[patent_app_country] => US
[patent_app_date] => 2004-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25978
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153332.pdf
[firstpage_image] =>[orig_patent_app_number] => 11000263
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/000263 | Method of diagnosing, monitoring, staging, imaging and treating colon cancer | Nov 29, 2004 | Abandoned |
Array
(
[id] => 7005703
[patent_doc_number] => 20050171016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Thrombospondin-2 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/997699
[patent_app_country] => US
[patent_app_date] => 2004-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25903
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171016.pdf
[firstpage_image] =>[orig_patent_app_number] => 10997699
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/997699 | Thrombospondin-2 and uses thereof | Nov 23, 2004 | Abandoned |
Array
(
[id] => 7074768
[patent_doc_number] => 20050148036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Method for detecting a mononuclear cell phenotype related to a pro-tumor immune response'
[patent_app_type] => utility
[patent_app_number] => 10/997648
[patent_app_country] => US
[patent_app_date] => 2004-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19246
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148036.pdf
[firstpage_image] =>[orig_patent_app_number] => 10997648
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/997648 | Method for detecting a mononuclear cell phenotype related to a pro-tumor immune response | Nov 23, 2004 | Abandoned |
Array
(
[id] => 142063
[patent_doc_number] => 07691817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-06
[patent_title] => 'System and method for inhibiting cellular proliferation with tachykinins'
[patent_app_type] => utility
[patent_app_number] => 10/994170
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 17834
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/691/07691817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994170
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994170 | System and method for inhibiting cellular proliferation with tachykinins | Nov 18, 2004 | Issued |
Array
(
[id] => 4733417
[patent_doc_number] => 20080050396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients'
[patent_app_type] => utility
[patent_app_number] => 10/580016
[patent_app_country] => US
[patent_app_date] => 2004-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20809
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050396.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580016
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580016 | Proteins belonging to the Bcl-2 family and fragments thereof, and their use in cancer patients | Nov 17, 2004 | Issued |
Array
(
[id] => 7252582
[patent_doc_number] => 20050142594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer'
[patent_app_type] => utility
[patent_app_number] => 10/983578
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7642
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142594.pdf
[firstpage_image] =>[orig_patent_app_number] => 10983578
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/983578 | DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer | Nov 8, 2004 | Abandoned |
Array
(
[id] => 7178069
[patent_doc_number] => 20050123969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer'
[patent_app_type] => utility
[patent_app_number] => 10/983577
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7643
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123969.pdf
[firstpage_image] =>[orig_patent_app_number] => 10983577
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/983577 | DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer | Nov 8, 2004 | Abandoned |
Array
(
[id] => 5289927
[patent_doc_number] => 20090022657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Novel CXCL8 antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/573726
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8897
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022657.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573726
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573726 | Novel CXCL8 antagonists | Oct 21, 2004 | Abandoned |
Array
(
[id] => 177691
[patent_doc_number] => 07655399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'Methods for prenatal diagnosis of chromosomal abnormalities'
[patent_app_type] => utility
[patent_app_number] => 10/575119
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8944
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655399.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575119
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575119 | Methods for prenatal diagnosis of chromosomal abnormalities | Oct 7, 2004 | Issued |
Array
(
[id] => 588381
[patent_doc_number] => 07435554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-14
[patent_title] => 'Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)'
[patent_app_type] => utility
[patent_app_number] => 10/954037
[patent_app_country] => US
[patent_app_date] => 2004-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 17760
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/435/07435554.pdf
[firstpage_image] =>[orig_patent_app_number] => 10954037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/954037 | Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) | Sep 28, 2004 | Issued |
Array
(
[id] => 564004
[patent_doc_number] => 07465554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-16
[patent_title] => 'Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/952328
[patent_app_country] => US
[patent_app_date] => 2004-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7151
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/465/07465554.pdf
[firstpage_image] =>[orig_patent_app_number] => 10952328
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/952328 | Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof | Sep 28, 2004 | Issued |